NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
27/05/2024
Voltar para busca
Dado oficial do USPTO
ONCORE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
27/05/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 35, 42
Data de depósito
17/08/2012
Data de registro
03/12/2013
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/05/2024
Última transação
27/05/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Primeiro uso
17/08/2012
Primeiro uso no comércio
17/08/2012
Código do desenho
5
Tipo de titular
03
Localização do titular
Columbia, MD, US
Examinador
KHAN, ASMAT
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "ONCORE" in stylized text.
Titulares e representantes
Titulares
ADVARRA, INC.
ADVARRA TECHNOLOGY SOLUTIONS, INC.
ADVARRA RESEARCH TECHNOLOGIES, INC.
Forte Research Systems, Inc.
Representantes
Andrew J. Ferren Goulston & Storrs PC
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Providing downloadable software for use by pharmaceutical companies and others in the design and administration of scientific and medical research projects and of clinical trials for pharmaceuticals, medical devices and medical procedures; Providing downloadable software for use by pharmaceutical companies and others in data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects and regarding clinical trials for pharmaceuticals, medical devices and medical procedures
Classe 35
Managing databases for use by pharmaceutical companies and others in the design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; Managing databases for use by pharmaceutical companies and others in the data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures
Classe 42
Providing on-line non-downloadable software for use in design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; [ providing a website featuring non-downloadable software for use in the design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; ] Hosting, managing, developing, and maintaining [ web sites, ] software, and applications for use by pharmaceutical companies and others in the design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; Providing on-line non-downloadable software for use in data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures, providing a website featuring non-downloadable software for use in data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and [ regarding clinical trials for pharmaceuticals, medical devices and medical procedures; Hosting, managing, developing, and maintaining [ web sites, ] software, applications, and databases for use by pharmaceutical companies and others in data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures; Providing on-line non-downloadable software for use by pharmaceutical companies and others in the tracking and management of patients, specimens, equipment, materials, funding, schedules, and performance milestones and metrics involved in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures, providing a website featuring non-downloadable software for use by pharmaceutical companies and others in the tracking and management of patients, specimens, equipment, materials, funding, schedules, and performance milestones and metrics involved in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; Hosting, managing, developing, and maintaining [ web sites, ] software, and applications for use by pharmaceutical companies and others in the tracking and management of patients, specimens, equipment, materials, funding, schedules, and performance milestones and metrics involved in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; Providing on-line non-downloadable software for use by pharmaceutical companies and others in the monitoring and reporting of regulatory, standards, and safety compliance in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures, providing a website featuring non-downloadable software for use by pharmaceutical companies and others in the monitoring and reporting of regulatory, standards, and safety compliance in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; Hosting, managing, developing, and maintaining [ web sites, ] software, and applications for use by pharmaceutical companies and others in the monitoring and reporting of regulatory, standards, and safety compliance in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; consulting services regarding all of the foregoing
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
27/05/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
27/05/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/05/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
14/02/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
25/01/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/12/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/11/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
24/09/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/09/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/09/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/09/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
24/09/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
22/09/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
15/09/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/09/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/12/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/12/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/11/2019
E815
TEAS SECTION 8 & 15 RECEIVED
25/10/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
18/09/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/12/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
29/04/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
03/12/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/09/2013
PUBO
PUBLISHED FOR OPPOSITION
17/09/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/08/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
15/08/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/08/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
14/08/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/08/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
14/08/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/08/2013
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
14/08/2013
ALIE
ASSIGNED TO LIE
07/08/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/07/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/06/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/06/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/06/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/12/2012
GNRT
NON-FINAL ACTION E-MAILED
15/12/2012
CNRT
NON-FINAL ACTION WRITTEN
15/12/2012
DOCK
ASSIGNED TO EXAMINER
12/12/2012
MPMK
NOTICE OF PSEUDO MARK MAILED
28/08/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/08/2012
NWAP
NEW APPLICATION ENTERED
21/08/2012
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ONCORE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.